期刊文献+

冠状动脉粥样硬化患者细胞因子信号转导抑制剂1基因表达的临床意义 被引量:2

Clinical significance of SOCS1 gene polymorphism in patients with atherosclerosis of coronary artery
下载PDF
导出
摘要 目的通过检测冠状动脉粥样硬化患者细胞因子信号转导抑制剂1(SOCS1)基因多态性的表达及外周血中相关细胞因子的含量,来探讨SOCS1与细胞因子及左心室射血分数的关系及其在冠状动脉粥样硬化性心脏病发生、发展中的作用及临床意义。方法选择2012年1月~2014年12月新疆医科大学第一附属医院收治的冠心病患者196例为研究组,选择同期196名健康志愿者作为对照组。利用聚合酶链反应及单核苷酸多态性分析两组SOCS1基因的多态性,同时利用酶联免疫吸附测定(ELISA)法检测血浆中自介素-1β(IL-1β)、肿瘤坏死因子仪(TNF-α)、胱抑素C(Cys-C)、同型半胱氨酸(Hcy)的水平。结果研究组和对照组rs15677380、rs173516427等位基因频率比较差异有统计学意义(P〈0.05),rs15677380C等位基因和rs173516427G等位基因均为冠状动脉粥样硬化性心脏病的高危因素(OR=1.91、1.74),rs173516427和rs15677380不同基因型左心室射血分数和IL-1β、Cys-C差异有统计学意义(P〈0.05),其中rs173516427G/G基因型和rs15677380C/C基因型的左心室射血分数最低,IL-1β、Cys-C水平最高。其余各组间比较差异无统计学意义(P〉0.05)。结论SOCS1与冠状动脉粥样硬化的发病过程有一定的相关性,可能参与其发病过程。 Objective To explore the relationship of suppressor of cytokine signaling 1 (SOCS1) with cytokines and the left ventrieular ejection fraction, and the role they play in the occurrence and development of coronary heart disease by detecting the expression of SOCS1 gene polymorphism and the contents of related cytokines in peripheral blood of pa- tients with atherosclerosis of coronary artery. Methods 196 patients with coronary heart disease admitted to the First Affiliated Hospital of Xinjiang Medical University from January 2012 to December 2014 were chosen as the study group, 196 cases of healthy volunteers at the same time were chosen as control group. Polymerase chain reaction and single nueleotide polymorphism were used to analyze SOCSI gene polymorphisms of two groups, ELISA method was used to test intedeukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), cystatin c (Cys-C) and homocysteine (Hcy) lev- els in plasma. Results There were significant differences in allele frequencies of rs15677380 and rs173516427 between study group and control group (P 〈 0.05), rs15677380 C allele and rs173516427G alleles were the risk factors of coro- nary atherosclerotic heart disease (OR = 1.91, 1.74). There were statistically significant differences in left ventricular e- jection fraction, IL-1β and Cys-C between rs173516427 and rs15677380 (P 〈 0.05), among which, the left ventricular ejection fraction of rs173516427 G/G genotype and rs15677380 C/C genotype were the lowest, whereas the IL-1β and Cys-C levels of these genotype were the highest. There were no significant differences between the other groups (P 〉 0.05). Conclusion There is a certain relationship between the SOCS1 and pathogenesis of atherosclerosis of coronaryartery, SOCS1 may take part in the pathogenesas ol disease.
出处 《中国医药导报》 CAS 2016年第8期112-115,131,共5页 China Medical Herald
基金 新疆维吾尔自治区自然科学基金资助项目(2014211C076)
关键词 冠状动脉粥样硬化 细胞因子信号转导抑制剂1 细胞因子 多态性 Atherosclerosis of coronary artery Sup-pressor of cytokine signaling 1 Cytokines Polymor-phism
  • 相关文献

参考文献20

  • 1Barseghian A, Gawande D, Bajaj M. Adiponectin and vul- nerable atherosclerotic plaques [J]. J Am Coll Cardiol,2011, 57(7) :761-770. 被引量:1
  • 2Chen Z,Xu H. Anti-inflammatory and immunomodulatory mechanism of tanshinone IIA for atherosclerosis [Jl- Evid Based Complement Alternat Med, 2014,2014: 267976. 被引量:1
  • 3Chen SC, Lin YI, Huang B,et al. Salvianolic acid B sup- presses IFN-γ-induced JAK/STAT1 activation in endothe- lial cells [J]. Thromb Res, 2011,128 (6) : 560-564. 被引量:1
  • 4Kadowaki T,Yamauchi T,Okada-Iwabu M,et al. Adiponectin and its receptors:implica-tions for obesity-associated dis- eases and longevity [J]. Lancet Diabetes Endocrinol,2014, 2(1):8-9. 被引量:1
  • 5Sprague AH, Khalil RA. Inflammatory eytokines in vascu- lar dysfunction and vascular disease [J]. Biochem Pharma- eol, 2009,78 (6) : 539-552. 被引量:1
  • 6Hansson GK. Inflammation, atherosclerosis, and coronary artery disease [J]. N Engl Med, 2005,352(16) : 1685-1695. 被引量:1
  • 7Song X,Zhang Z,Wang S,et al. A Janus Kinase in the JAK/STAT signaling path-way from Litopenaeus vannamei is involved in antiviral immunity response [J]. Fish Shellfish Immunol, 2015,44(2) :662-673. 被引量:1
  • 8Legein B, Temmerman L, Biessen EAL, et al. Inflammation and immune system interactions in atherosclerosis [J]. Cellular and Molecular Life Sciences,2013,70 (20):3847- 3869. 被引量:1
  • 9Sygitowicz G, Janas J, Bialek S,et al. Ischaemia modified albumin in patients with acute coronary syndrome and negative cardiac troponin I[J]. Scand J Clin Lab Invest, 2013,73(2) : 130-134. 被引量:1
  • 10Kaptoge S, Seshasai SR, Gao P, et al. Inflammatory cytokines and risk of coronary heart disease:new prospective study and updated meta-analysis [J]. Eur Heart J, 2014,35(9) : 578-589. 被引量:1

二级参考文献43

  • 1白书玲,李建军.C反应蛋白与动脉粥样硬化[J].中华心血管病杂志,2004,32(8):765-768. 被引量:133
  • 2庄晓峰,许朝祥,杜心清.纤维蛋白原与超敏C-反应蛋白、冠状动脉病变的相关性[J].福建医科大学学报,2006,40(2):150-153. 被引量:35
  • 3陈灏珠.冠状动脉粥样硬化和冠状动脉粥样硬化性心脏病[M] //陆再英,钟南山.内科学.7版.北京:人民卫生出版社,2008:268-174. 被引量:1
  • 4Brown TM,Bittner V.Biomarkers of atherosclerosis:Clinical applications[J].Curr Cardiol Rep,2008,10(6):497-504. 被引量:1
  • 5Gensini GG.A more meaningful scoring system for determining the severity of coronary heart disease[J].Am J Cardio,1983,51(3):606. 被引量:1
  • 6Till K,Claudia MM,Edith L,et a1.Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function:results from the athergene study[J].Eur Heart J,2009,30(3):314-320. 被引量:1
  • 7Kazunori S.Immune system and atherosclerotic diaease-heterogeneity of leukocyte subsets participating in the pathogenesis of atherosclerosis[J].Circ J,2009,73(6):994-1001. 被引量:1
  • 8Akihiko Y,Tetsuji N,Masato K,et al.SOCS proteins,cytokine signalling and immune regulation[J].Nat Rev Immunol,2007,7(6):454-465. 被引量:1
  • 9Tan J C,Rabkin R.Suppressor of cytokine signaling in health and disease[J].Pediatr Nephrol,2005,20(5):567-575. 被引量:1
  • 10Swirski F K,Libby P,Aikawa E,et al.Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata[J].J Clin Invest,2007,117(1):195-205. 被引量:1

共引文献29

同被引文献37

  • 1王玉仙,马学荣.泽泻汤加味治疗高脂血症103例[J].陕西中医,2005,26(2):103-104. 被引量:14
  • 2庄庭怡,毛静远.冠心病心绞痛与肿瘤坏死因子-α、白介素-1β及白介素-6关系的研究概况[J].中国心血管病研究,2007,5(8):613-615. 被引量:26
  • 3Blann AD. Plasma von Willebrand factor, thrombosis andthe endothelium:The fist 30 years [J]. Thromb hamost,2006,95:49-55. 被引量:1
  • 4Sonneveld MA,de Maat MP,Leebeek FW. Von Willebrandfactor and ADAMTS13 in arterial thrombosis : a systemat-ic review and meta-analysis [J]. Blood Rev,2014,104:1100-1103. 被引量:1
  • 5Reminger AJ,Heijinen HH, Schumannn H,et al. Mechin-ism of Platelet adhesion to von Willebran factor and mi-croparticel formation under high shear stress [J]. Blood,2006,107:3537-3545. 被引量:1
  • 6Montoro-Garcia S, Shantsila E,Lip GY. Potential value oftargeting von Willebrand factor in atherosclerotic cardio-vascular disease [J]. Expert Opin Ther Targets,2014,18(1):43-53. 被引量:1
  • 7Van Galen KP,Tuinenburg A,Smeets EM,et al. Von Wille-brand factor deficiency and atherosclerosis [J]. Blood Rev,2012,26(5):189-196. 被引量:1
  • 8Sramek A, Bucciarelli P,Federici AB,et al. Patients withtype 3 severevon Willebrand disease are not protected a-gainst atherosclerosis results from a multicenter study in47 patients [J] Circulation, 2004,109 : 740-744. 被引量:1
  • 9Ristic GG,Subota V,Lepic T,et al. Subclinical atheroscle-rosis in patients with rheumatoid arthritis and low cardio-vascular risk : the role of von Willebrand Factor activity[J]. PLoS One,2015,10(8):e0130462. 被引量:1
  • 10Willeit P,Thompson A,Aspelund T,et al. Hemostatic factorsand risk of coronary heart disease in general populations :new prospective study and updated meta -analyses [J].PLoS One,2013,8(2):e55175. 被引量:1

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部